All Pharma News
Biogen cost cuts drive profit beat, as Alzheimer`s drug off to slow start

Biogen cost cuts drive profit beat, as Alzheimer`s drug off to slow start
REUTERS
25 Apr 2024
Share Share
Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024

Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024
PR NEWSWIRE
24 Apr 2024
Share Share
Alzheimer`s drug adoption in US slowed by doctors` skepticism

Alzheimer`s drug adoption in US slowed by doctors` skepticism
Julie Steenhuysen REUTERS
23 Apr 2024
Share Share
BioArctic, Eisai Sign BAN2802 Research Evaluation Agreement

BioArctic, Eisai Sign BAN2802 Research Evaluation Agreement
PR NEWSWIRE
20 Apr 2024
Share Share
Eisai`s antiepileptic drug Fycompa injection formulation launches in Japan

Eisai`s antiepileptic drug Fycompa injection formulation launches in Japan
BIOSPECTRUM ASIA
18 Apr 2024
Share Share
Lilly glides out of Leqembi slipstream with FDA meeting request

Lilly glides out of Leqembi slipstream with FDA meeting request
FIERCE BIOTECH
17 Apr 2024
Share Share
Eisai`s Robust Neurology Portfolio At AAN 2024

Eisai`s Robust Neurology Portfolio At AAN 2024
PR NEWSWIRE
12 Apr 2024
Share Share
French sales sub. of Eisai divests rights of neurology drugs for € 56.5 M

French sales sub. of Eisai divests rights of neurology drugs for € 56.5 M
BIOSPECTRUMASIA
08 Apr 2024
Share Share
Eisai, Biogen`s subQ Leqembi delayed amid FDA`s data request

Eisai, Biogen`s subQ Leqembi delayed amid FDA`s data request
FIERCE PHARMA
02 Apr 2024
Share Share
Submission of Leqembi® sBLA for the treatment of early AD to the FDA completed

Submission of Leqembi® sBLA for the treatment of early AD to the FDA completed
PR NEWSWIRE
31 Mar 2024
Share Share